Global NGS-based RNA-seq Market Growth (Status and Outlook) 2023-2029

Global NGS-based RNA-seq Market Growth (Status and Outlook) 2023-2029

Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.

LPI (LP Information)' newest research report, the “NGS-based RNA-seq Industry Forecast” looks at past sales and reviews total world NGS-based RNA-seq sales in 2022, providing a comprehensive analysis by region and market sector of projected NGS-based RNA-seq sales for 2023 through 2029. With NGS-based RNA-seq sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NGS-based RNA-seq industry.

This Insight Report provides a comprehensive analysis of the global NGS-based RNA-seq landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on NGS-based RNA-seq portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global NGS-based RNA-seq market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NGS-based RNA-seq and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NGS-based RNA-seq.

The global NGS-based RNA-seq market size is projected to grow from US$ 1501.1 million in 2022 to US$ 3261.2 million in 2029; it is expected to grow at a CAGR of 11.7% from 2023 to 2029.

The hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics.

This report presents a comprehensive overview, market shares, and growth opportunities of NGS-based RNA-seq market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
High-Throughput Sequencing
Third-Generation Sequencing Technology

Segmentation by application
Hospitals and Clinics
Biopharma Companies
Government Agencies
Academic and Research Organizations
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher Scientific
Pacific Biosciences Of California
Qaigen
F. Hoffmann-La Roche
Agilent Technologies
Oxford Nanopore Technologies
Perkinelmer
Eurofins Scientific
Gatc Biotech
Macrogen

Please note: The report will take approximately 2 business days to prepare and deliver.